BioSpace News Archive

BioMidwest

Anteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023

Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR) announced today that Wayne Paterson, the Chief Executive Officer of Anteris will present at the Cantor Fitzgerald Annual Global Healthcare Conference in New York, NY on Tuesday, September 26, 2023, at 2:45 p.m. Eastern Time.

September 12, 2023

·

2 min read

Biotech Beach

Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock - September 13, 2023

Crinetics Pharmaceuticals, Inc. announced the pricing of an upsized underwritten public offering of 11,441,648 shares of its common stock at a price to the public of $30.59 per share.

September 12, 2023

·

5 min read

BioMidwest

ZyVersa Therapeutics Announces Research Published in Frontiers in Immunology Reinforcing IC 100’s Rationale for Inhibiting Multiple Inflammasomes to Control Inflammation in Various Inflammatory Diseases

ZyVersa Therapeutics, Inc. announces publication of a paper in the peer-reviewed journal, Frontiers in Immunology, highlighting potential limitations of NLRP3 inhibition in attenuating CNS Inflammation associated with activation of multiple inflammasome pathways.

September 12, 2023

·

6 min read

Policy

Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the Treatment of Patients with Relapsed or Refractory Hodgkin Lymphoma

Affimed N.V. announced that the FDA has granted fast track designation to the combination of its innate cell engager AFM13 with AlloNK® for the potential treatment of relapsed/refractory Hodgkin lymphoma.

September 12, 2023

·

9 min read

BioMidwest

Avanos Medical, Inc. to Present at the CL King Annual Best Ideas Conference

Avanos Medical, Inc. announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King’s virtual 21st Annual Best Ideas Conference 2023 on Mon., Sept. 18 at approximately 8:45 a.m. Eastern Time.

September 12, 2023

·

1 min read

Lone Star Bio

The Caris Precision Oncology Alliance Welcomes Loyola University Chicago’s Stritch School of Medicine

Caris Life Sciences®, announced that Loyola University Chicago’s Stritch School of Medicine has joined the Caris Precision Oncology Alliance™.

September 12, 2023

·

4 min read

Business

Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors

Protalix BioTherapeutics, Inc. announced that the Company’s Board of Directors has appointed Eliot Richard Forster, Ph.D.

September 12, 2023

·

5 min read

Genetown

2seventy bio and JW Therapeutics Announce Intent To Expand Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies and Autoimmune Therapies

2seventy bio, Inc. and JW Therapeutics announced their intention to expand their strategic alliance.

September 12, 2023

·

8 min read

Virios Therapeutics CEO Greg Duncan to Present at the SHARE™️ Series Investor Event on Monday, September 18, 2023

Virios Therapeutics, Inc. announced today that Greg Duncan, Chairman and Chief Executive Officer, will present at the SHARE™️ Series Monday Management Update for investors on Monday, September 18, 2023, at 11:00 am ET.

September 12, 2023

·

3 min read

Bio NC

Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health Equity

Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, announced a strategic collaboration that will expand its relationship with Oracle.

September 12, 2023

·

3 min read